Loading...
Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts
BACKGROUND: The combination of EGFR tyrosine kinase inhibitors (TKIs) and chemotherapy is thought to increase treatment efficacy in non‐small‐cell lung cancer (NSCLC). This study investigated the efficacy and potential mechanisms of different combined modes of icotinib plus pemetrexed in EGFR‐mutant...
Saved in:
| Published in: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley & Sons Australia, Ltd
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6119608/ https://ncbi.nlm.nih.gov/pubmed/30047610 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12818 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|